Table 1 Analysis of the clinical data of patients in the training set (\(\bar x \pm \;{\rm{s}}\))
Index | Control group (n = 30) | Benign lung nodule group (n = 34) | Malignant pulmonary nodule group (n = 31) |
|---|---|---|---|
Age (years) | 65.38 ± 5.24 | 67.51 ± 6.38 | 66.42 ± 4.75 |
Gender (male/female) | 18/12 | 21/13 | 20/11 |
BMI(kg/m2) | 23.54 ± 2.05 | 22.39 ± 1.88 | 23.56 ± 2.17 |
Nodule size (cm) | - | 1.77 ± 0.24 | 2.65 ± 0.35 |
NSCLC staging | - | - | |
I | - | - | 12(38.71%) |
II | - | - | 8(25.81%) |
III-IV | - | - | 11(35.48%) |
Glandular cancer | - | - | 17(54.83%) |
Squamous cell carcinoma | - | - | 14(45.17%) |
Benign inducement | - | - | - |
Inflammatory lesion | - | 23(67.64%) | - |
Meat quality | - | 3(8.82%) | - |
Granuloma | - | 3(8.82%) | - |
Fibrosis | - | 2(14.72%) | - |